• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

息肉样脉络膜血管病变和新生血管性年龄相关性黄斑变性的慢性低度炎症的血浆标志物。

Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.

机构信息

Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.

Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.

出版信息

Acta Ophthalmol. 2019 Feb;97(1):99-106. doi: 10.1111/aos.13886. Epub 2018 Oct 4.

DOI:10.1111/aos.13886
PMID:30288946
Abstract

PURPOSE

Ageing is the strongest predictor of neovascular age-related macular degeneration (AMD), where neuroinflammation is known to play a major role. Less is known about polypoidal choroidal vasculopathy (PCV), which is an important differential diagnosis to neovascular AMD. Here, we report plasma markers of inflammation with age (inflammaging) in patients with PCV, patients with neovascular AMD and a healthy age-matched control group.

METHODS

We isolated plasma from fresh venous blood obtained from participants (n = 90) with either PCV, neovascular AMD, or healthy maculae. Interleukin(IL)-1β, IL-6, IL-8, IL-10 and tumour necrosis factor receptor 2 (TNF-R2) were measured using U-PLEX Human Assays. Routine plasma C-reactive protein (CRP) was measured using Dimension Vista 1500.

RESULTS

Patients with PCV had plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-R2 similar to that in healthy controls. Patients with neovascular AMD had significantly higher plasma IL-1β, IL-6 and IL-10 than healthy controls, whereas no significant differences were observed for plasma IL-8 and TNF-R2. Differences between plasma IL-1β, IL-6 and IL-10 possessed a positive but weak ability in discriminating neovascular AMD from PCV. Both patients with PCV and patients with neovascular AMD had significantly higher levels of routine plasma CRP.

CONCLUSION

Patients with PCV differ from patients with neovascular AMD in terms of plasma inflammaging profile. Apart from increased CRP, no signs of inflammaging were observed in patients with PCV. In patients with neovascular AMD, we find a specific angiogenesis-twisted inflammaging profile.

摘要

目的

衰老(aging)是年龄相关性黄斑变性(AMD)中新生血管形成的最强预测因子,已知神经炎症(neuroinflammation)在此过程中发挥重要作用。关于息肉样脉络膜血管病变(PCV),其是新生血管性 AMD 的重要鉴别诊断,人们了解较少。在此,我们报告了 PCV 患者、新生血管性 AMD 患者和健康年龄匹配对照组中与年龄相关的炎症标志物(inflammaging)。

方法

我们从 PCV、新生血管性 AMD 或健康黄斑患者的新鲜静脉血中分离血浆。使用 U-PLEX 人分析物测量白细胞介素(IL)-1β、IL-6、IL-8、IL-10 和肿瘤坏死因子受体 2(TNF-R2)。使用 Dimension Vista 1500 测量常规血浆 C 反应蛋白(CRP)。

结果

PCV 患者的血浆 IL-1β、IL-6、IL-8、IL-10 和 TNF-R2 水平与健康对照组相似。新生血管性 AMD 患者的血浆 IL-1β、IL-6 和 IL-10 水平明显高于健康对照组,而 IL-8 和 TNF-R2 则无显著差异。区分新生血管性 AMD 和 PCV 的血浆 IL-1β、IL-6 和 IL-10 差异具有正相关但较弱的能力。PCV 患者和新生血管性 AMD 患者的常规血浆 CRP 水平均显著升高。

结论

PCV 患者与新生血管性 AMD 患者的血浆炎症标志物谱不同。除了 CRP 增加外,PCV 患者未观察到炎症迹象。在新生血管性 AMD 患者中,我们发现了一种特定的血管生成扭曲的炎症标志物谱。

相似文献

1
Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.息肉样脉络膜血管病变和新生血管性年龄相关性黄斑变性的慢性低度炎症的血浆标志物。
Acta Ophthalmol. 2019 Feb;97(1):99-106. doi: 10.1111/aos.13886. Epub 2018 Oct 4.
2
Altered proportion of CCR2 and CX3CR1 circulating monocytes in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.在新生血管性年龄相关性黄斑变性和息肉状脉络膜血管病变中,循环单核细胞中 CCR2 和 CX3CR1 的比例发生改变。
Clin Exp Ophthalmol. 2018 Aug;46(6):661-669. doi: 10.1111/ceo.13152. Epub 2018 Mar 4.
3
Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.典型新生血管性年龄相关性黄斑变性与息肉样脉络膜血管病变的黄斑中心凹下脉络膜结构比较。
Jpn J Ophthalmol. 2018 Sep;62(5):576-583. doi: 10.1007/s10384-018-0615-4. Epub 2018 Aug 1.
4
Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.脉络膜大血管层的形态学特征:年龄相关性黄斑变性、息肉样脉络膜血管病变和中心性浆液性脉络膜视网膜病变。
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2309-2317. doi: 10.1007/s00417-018-4143-1. Epub 2018 Sep 27.
5
Fundus autofluorescence in polypoidal choroidal vasculopathy.眼底自发荧光在息肉样脉络膜血管病变中的应用。
Ophthalmology. 2012 Aug;119(8):1650-7. doi: 10.1016/j.ophtha.2012.02.016. Epub 2012 Apr 17.
6
DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.年龄相关性黄斑变性和息肉状脉络膜血管病变中脉络膜形态学和血管特征的详细表征
Retina. 2017 Dec;37(12):2269-2280. doi: 10.1097/IAE.0000000000001481.
7
Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.呈现未经治疗的渗出性年龄相关性黄斑变性的斯堪的纳维亚患者中息肉样脉络膜血管病变的特征和流行情况。
Acta Ophthalmol. 2018 Aug;96(5):475-480. doi: 10.1111/aos.13646. Epub 2017 Nov 30.
8
Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images.通过扫频源光学相干断层扫描图像二值化确定的息肉状脉络膜血管病变、新生血管性年龄相关性黄斑病变和健康眼中的脉络膜结构。
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):935-943. doi: 10.1007/s00417-017-3591-3. Epub 2017 Feb 1.
9
Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.息肉样脉络膜血管病变患者和新生血管性年龄相关性黄斑变性患者的C反应蛋白水平升高。
Ophthalmology. 2007 Sep;114(9):1722-7. doi: 10.1016/j.ophtha.2006.12.021. Epub 2007 Apr 2.
10
Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.阿柏西普治疗典型年龄相关性黄斑变性和息肉状脉络膜血管病变后的预后因素。
Jpn J Ophthalmol. 2018 Sep;62(5):584-591. doi: 10.1007/s10384-018-0605-6. Epub 2018 Jul 4.

引用本文的文献

1
Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review.眼科类固醇治疗息肉样脉络膜血管病变的疗效与安全性:一项系统评价
Clin Ophthalmol. 2025 Mar 15;19:915-931. doi: 10.2147/OPTH.S517296. eCollection 2025.
2
Systemic oxidative stress levels and their associations with the risk of neovascular age-related macular degeneration and treatment response.全身氧化应激水平及其与新生血管性年龄相关性黄斑变性风险和治疗反应的关联。
Int J Retina Vitreous. 2025 Feb 10;11(1):16. doi: 10.1186/s40942-025-00632-1.
3
Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches.
血管炎症衰老的潜在机制:当前见解与潜在治疗方法
Aging Dis. 2024 Oct 18;16(4):1889-1917. doi: 10.14336/AD.2024.0922.
4
Intraocular Concentration of Stem Cell Factor/c-KIT and Galectin-1 in Retinal Diseases.眼内干细胞因子/c-KIT 和半乳糖凝集素-1 在视网膜疾病中的浓度。
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):11. doi: 10.1167/iovs.65.11.11.
5
Tocilizumab attenuates choroidal neovascularization by regulating macrophage polarization through the IL-6R/STAT3/VEGF pathway.托珠单抗通过IL-6R/STAT3/VEGF途径调节巨噬细胞极化来减轻脉络膜新生血管形成。
Heliyon. 2024 Mar 14;10(6):e27893. doi: 10.1016/j.heliyon.2024.e27893. eCollection 2024 Mar 30.
6
Interleukin-8 Promoter Polymorphism -251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration.白细胞介素-8启动子多态性-251A/T与新生血管性年龄相关性黄斑变性的治疗反应
Clin Ophthalmol. 2024 Feb 21;18:537-543. doi: 10.2147/OPTH.S448794. eCollection 2024.
7
Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review.雷珠单抗眼内注射给药系统的临床试验及未来展望:一项叙述性综述
Ophthalmol Ther. 2024 Jan;13(1):51-69. doi: 10.1007/s40123-023-00843-5. Epub 2023 Dec 6.
8
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.眼部血管疾病:从视网膜免疫特惠到炎症。
Int J Mol Sci. 2023 Jul 28;24(15):12090. doi: 10.3390/ijms241512090.
9
The role of the cytokine TNF-α in choroidal neovascularization: a systematic review.细胞因子 TNF-α 在脉络膜新生血管中的作用:系统评价。
Eye (Lond). 2024 Jan;38(1):25-32. doi: 10.1038/s41433-023-02634-5. Epub 2023 Jun 28.
10
Is Erythrocyte Sedimentation Rate Necessary for the Initial Diagnosis of Giant Cell Arteritis?红细胞沉降率对巨细胞动脉炎的初始诊断是否必要?
Life (Basel). 2023 Mar 3;13(3):693. doi: 10.3390/life13030693.